|
| 38088796 | Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria. | Emerg Microbes Infect | 2024 |
| 36737435 | Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. | Nat Commun | 2023 |
| 37561630 | Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes. | Cell Rep | 2023 |
| 37793212 | Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine. | EBioMedicine | 2023 |
| 37544326 | Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial. | Lancet Infect Dis | 2023 |
| 37026013 | Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters. | Front Immunol | 2023 |
| 37390836 | Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial. | Lancet Infect Dis | 2023 |
| 37023746 | Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. | Cell Rep Med | 2023 |
| 37132356 | Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief report. | J Public Health (Oxf) | 2023 |
| 37267710 | Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional setting. | Epidemics | 2023 |
| 37395646 | Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity. | J Virol | 2023 |
| 36934088 | SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies. | NPJ Vaccines | 2023 |
| 34705557 | Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques. | J Virol | 2022 |
| 35543272 | Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019. | J Infect Dis | 2022 |
| 35641901 | Myopericarditis associated with acute Zika virus infection: a case report. | BMC Infect Dis | 2022 |
| 35632473 | A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model. | Vaccines (Basel) | 2022 |
| 36962352 | Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021. | PLOS Glob Public Health | 2022 |
| 36417525 | Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. | Sci Adv | 2022 |
| 36206315 | Prioritizing interventions for preventing COVID-19 outbreaks in military basic training. | PLoS Comput Biol | 2022 |
| 35987764 | Author Correction: Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets. | NPJ Vaccines | 2022 |
| 36220131 | Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand. | Emerg Infect Dis | 2022 |
| 35130924 | Neurocognitive impact of Zika virus infection in adult rhesus macaques. | J Neuroinflammation | 2022 |
| 34914540 | A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. | Sci Transl Med | 2022 |
| 35089535 | HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development. | Curr HIV/AIDS Rep | 2022 |
| 35087081 | Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets. | NPJ Vaccines | 2022 |
| 35029310 | Innovative vaccine approaches-a Keystone Symposia report. | Ann N Y Acad Sci | 2022 |
| 33400705 | Cohort profile: Study on Zika virus infection in Brazil (ZIKABRA study). | PLoS One | 2021 |
| 33717194 | Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine. | Front Immunol | 2021 |
| 33851155 | Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. | bioRxiv | 2021 |
| 33791694 | Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates. | bioRxiv | 2021 |
| 33784358 | Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4. | PLoS One | 2021 |
| 33587687 | A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine. | Ann Intern Med | 2021 |
| 33664734 | Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development. | Front Immunol | 2021 |
| 33503145 | Zika virus RNA excretion in sweat with concomitant detection in other body fluid specimens. | Mem Inst Oswaldo Cruz | 2021 |
| 34919799 | SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. | Cell Rep | 2021 |
| 34903722 | SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses. | NPJ Vaccines | 2021 |
| 34470866 | Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. | Proc Natl Acad Sci U S A | 2021 |
| 34462471 | A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic. | Sci Rep | 2021 |
| 34514020 | Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population. | Open Forum Infect Dis | 2021 |
| 34716452 | Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. | Nat Immunol | 2021 |
| 34452470 | The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response. | Viruses | 2021 |
| 34711815 | A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. | NPJ Vaccines | 2021 |
| 34159328 | A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters. | bioRxiv | 2021 |
| 34013273 | SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. | bioRxiv | 2021 |
| 34170962 | Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice. | PLoS Pathog | 2021 |
| 34081747 | Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform. | PLoS One | 2021 |
| 32325036 | Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? | Lancet Infect Dis | 2020 |
| 32015557 | Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor. | Nat Med | 2020 |
| 32807807 | Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. | Nat Commun | 2020 |
| 32649880 | Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks. | Cell | 2020 |